Left atrial appendage closure concomitant with cardiac surgery
Why the trial?
Surgical closure of the left atrial appendage during cardiac surgery may prevent later stroke, but evidence outside patients with known atrial fibrillation is limited. LAACS-2 tested routine concomitant appendage closure at the time of cardiac surgery.
Does concomitant left atrial appendage closure reduce stroke or TIA in patients undergoing first-time planned open-heart surgery?
Population
1,500 first-time planned open-heart surgery patients; mean age 67, 4.1% with AF
Comparison
Concomitant surgical LAA closure vs standard care (appendage left open)
Design
Multicenter 1:1 randomized trial (4 sites: Denmark, Spain, Sweden)
Follow-up
Median 4.0 years
Key result
Concomitant left atrial appendage closure did not significantly reduce stroke or TIA compared to standard care (4.28% vs 5.04%; HR 0.85; 95% CI 0.53-1.37; p=0.517).
Authors
LAACS-2 tested whether surgical left atrial appendage closure should be added routinely to planned open-heart surgery, including in patients without prior atrial fibrillation. Over a median 4.0 years it did not significantly reduce stroke or TIA versus standard care (4.28% vs 5.04%; HR 0.85, 95% CI 0.53-1.37; p=0.517). Expert reaction to the earlier LAACS data had been divided; the new readout leaves routine closure unsupported overall, with a signal in patients whose CHA2DS2-VASc was above the median.
Split on whether LAACS data support routine appendage closure
1 take classified by contention axis so far — the map appears as more land.
Whether the high-CHA2DS2-VASc subgroup signal will hold in LeAAPS and LAA-CLOSURE, and whether longer LAACS-2 follow-up changes the overall null, remains open.
For surgeons, left atrial appendage occlusion is a reasonable thing to do for patients at high risk of developing atrial fibrillation, but there is not a clear signal one way or the other. It would also be reasonable not to perform it.
Despite tackling an important clinical question, the LAACS study does not deliver a definitive answer on routine surgical appendage closure.
Based on the study findings, it would be advisable to routinely add surgical closure of the left atrial appendage to planned open heart surgery.
Does not reduce stroke or TIA with routine LAA closure; challenges broad adoption and leaves high CHA2DS2-VASc benefit for targeted trials.
| Outcome | LAA closure | Open LAA |
|---|---|---|
| Stroke or TIA | 4.28% | 5.04% |
| Primary endpoint · HR 0.85 (95% CI 0.53-1.37); p=0.517 | ||
| Stroke or TIA, CHA2DS2-VASc above median | ||
| Subgroup · 56% relative reduction (p=0.018); per-arm rates not reported; no benefit at lower stroke risk | ||
Representation
Only 4.1% of patients had atrial fibrillation at baseline, so the result mainly addresses patients without an anticoagulation indication.
Subgroup caution
The CHA2DS2-VASc subgroup benefit is hypothesis-generating; per-arm subgroup rates are not reported.
Statistical certainty
The wide CI (0.53–1.37) leaves room for a meaningful overall benefit.
Design limitations
No surgical safety or complication data are reported in the record.
Does concomitant left atrial appendage closure reduce stroke or TIA in patients undergoing first-time planned open-heart surgery?
Routine concomitant left atrial appendage closure during first-time open-heart surgery did not significantly reduce the overall risk of stroke or TIA, though a benefit was observed in patients with higher baseline CHA2DS2-VASc scores.
Hazard Ratio: 0.85 (95% CI 0.53–1.37)
Absolute Event Rate: 4.28% vs 5.04%
p-value: p=0.517
Helena Dominguez (2026) conducted an RCT in first-time planned open-heart surgery (n=1,500). Concomitant left atrial appendage closure vs. Standard care (open LAA) was evaluated on stroke or TIA (HR 0.85, 95% CI 0.53-1.37, p=0.517). Concomitant left atrial appendage closure did not significantly reduce stroke or TIA compared to standard care (4.28% vs 5.04%; HR 0.85; 95% CI 0.53-1.37; p=0.517).